Dr. Lal Pathlabs Faces Technical Shift Amid Strong Long-Term Performance and High Valuation
Dr. Lal Pathlabs has recently experienced an evaluation adjustment reflecting changes in its technical trends, shifting to a mildly bearish stance. The company reported a 5.02% return over the past year and a 36.2% increase in profits, despite a decline in stock performance relative to the Sensex.
Dr. Lal Pathlabs, a prominent player in the healthcare services industry, has recently undergone an evaluation adjustment that reflects changes in its underlying technical trends. The stock's technical indicators have shifted, moving from a sideways trend to a mildly bearish stance. This adjustment is influenced by various technical metrics, including the MACD and KST, which indicate a mixed outlook over different time frames.In terms of performance, Dr. Lal Pathlabs has reported a return of 5.02% over the past year, while its profits have increased by 36.2%. However, the company has experienced a decline in stock performance relative to the Sensex over shorter periods, including a year-to-date return of -7.03%. Despite a strong return over the long term, the stock's valuation appears high, with a Price to Book Value ratio of 10.7, suggesting a premium compared to its peers.
The company maintains a solid management efficiency, evidenced by a high return on equity (ROE) of 22.4%, and a low debt-to-equity ratio, indicating a stable financial position. With institutional holdings at 39.99%, Dr. Lal Pathlabs continues to attract significant interest from larger investors who are well-equipped to analyze its fundamentals.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
